Exelixis
EXEL
#1674
Rank
NZ$21.27 B
Marketcap
NZ$79.03
Share price
3.47%
Change (1 day)
33.41%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company